Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden
Authors
Keywords
-
Journal
CIRCULATION
Volume 146, Issue 11, Pages 836-847
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-09-13
DOI
10.1161/circulationaha.122.060274
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation
- (2022) A. John Camm et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure
- (2021) Andreas Rillig et al. CIRCULATION
- Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial
- (2021) Andreas Metzner et al. EUROPACE
- Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial
- (2021) Stephan Willems et al. EUROPEAN HEART JOURNAL
- Efficacy and Safety of Ablation for Symptomatic Atrial Fibrillation in Elderly Patients: A Meta-Analysis
- (2021) Wei-Chieh Lee et al. Frontiers in Cardiovascular Medicine
- Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results from the CABANA Trial
- (2021) Tristram D. Bahnson et al. CIRCULATION
- Catheter ablation for atrial fibrillation in elderly patients: Systematic review and a meta‐analysis
- (2021) Iwanari Kawamura et al. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- CHA2DS2-VASc score stratifies mortality risk in patients with and without atrial fibrillation
- (2021) Serge C Harb et al. Open Heart
- Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association
- (2020) Mina K. Chung et al. CIRCULATION
- Epidemiology of Atrial Fibrillation in the 21st Century
- (2020) Jelena Kornej et al. CIRCULATION RESEARCH
- Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: One year follow up of the prospective observational ETNA-AF-Europe study
- (2020) Joris R de Groot et al. European Heart Journal-Cardiovascular Pharmacotherapy
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)
- (2020) Gerhard Hindricks et al. EUROPEAN HEART JOURNAL
- Early Rhythm-Control Therapy in Patients with Atrial Fibrillation
- (2020) Paulus Kirchhof et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mortality Prediction of the CHA2DS2-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation
- (2020) Doralisa Morrone et al. Journal of Clinical Medicine
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant)
- (2019) Andrea Gažová et al. MEDICINE
- Global Prospective Safety Analysis of Rivaroxaban
- (2018) Paulus Kirchhof et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and safety of cryoballoon ablation in the elderly: A multicenter study
- (2018) Christian-Hendrik Heeger et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cryoballoon ablation in the elderly: one year outcome and safety of the second-generation 28mm cryoballoon in patients over 75 years old
- (2017) Verena Tscholl et al. EUROPACE
- Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
- (2017) José A López-López et al. BMJ-British Medical Journal
- Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
- (2017) José A López-López et al. BMJ-British Medical Journal
- EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication
- (2016) Andreas Goette et al. EUROPACE
- Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries
- (2016) Leif Friberg et al. EUROPEAN HEART JOURNAL
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- 5 year mortality predictors in 498 103 UK Biobank participants: a prospective population-based study
- (2015) Andrea Ganna et al. LANCET
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study
- (2012) L. Friberg et al. BMJ-British Medical Journal
- Risk Factors for Stroke and Thromboembolism in Relation to Age Among Patients With Atrial Fibrillation
- (2011) Jonas Bjerring Olesen et al. CHEST
- Dronedarone in High-Risk Permanent Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of Stroke in ATHENA: A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter
- (2009) Stuart J. Connolly et al. CIRCULATION
- Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
- (2009) Stefan H. Hohnloser et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started